Hedera Dx Alternatives & Competitors
12 companies similar to Hedera Dx — Modern cancer care for the next billion people
Companies similar to Hedera Dx
Guardant Health
Conquering Cancer With Data
Palo Alto, United States
CellMax Life
Liquid biopsy company focused on cancer screening with a proprietary platform for detectin...
Sunnyvale, United States
Predicine
Advancing precision medicine through next-generation liquid biopsy oncology platform
Hayward, United States
Personal Genome Diagnostics
Leading the way in patient-specific cancer genome analysis with groundbreaking technologie...
Track all Hedera Dx competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Beijing, China
Japan
Droplet Biosciences, Inc
Harnessing lymphatic fluid's powerful insights to improve cancer care through the first ly...
Cambridge, United States
Diatech Pharmacogenetics
Leader in the development, production and sales of pharmacogenetics tests for cancer preci...
Jesi, Italy
Personalis, Inc.
Ultrasensitive ctDNA testing
Fremont, United States
NVIGEN Inc.
Molecularly Engineered Nanoparticles to Advance Personalized Medicine
San Jose, United States
Kite Pharma
At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer.
Santa Monica, United Stat...
Xilio Therapeutics, Inc.
Focused on harnessing the immune system to achieve deep and durable clinical responses to...
Waltham, United States
About Hedera Dx
Hedera Dx, founded in 2021, is a Swiss-based startup in the Health Care industry, poised to revolutionize cancer diagnostics. With the slogan, "Modern cancer care to the next billion people," the company offers innovative NGS-based liquid biopsies. These non-invasive tests not only facilitate early diagnosis but also e...
Liquid Biopsy Solutions, Tumor Profiling Kits, Software & Analysis for Cancer Treatment, Implementation Programs for Hospital Labs, Clinical Studies and Trials
Hospital Laboratories, Oncologists, Healthcare Providers, Cancer Patients, Clinical Researchers
Modern Cancer Care, Liquid Biopsy, Next-Generation Sequencing, Non-Invasive Diagnosis, Timely Treatment Selection, Longitudinal Disease Monitoring, Clinic-Ready Solutions, Tumor Profiling, IVD Compliance, Privacy Infrastructure, Precision Medicine, CtDNA, Medical Device, Oncology, Innovative Work Environment
B2B, D2C, SaaS
Product Sales, Service Fee, Licensing
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Hedera Dx and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Hedera Dx on 13 Nov 2025. The 12 companies listed here were last checked between 11 Sep 2024 and 10 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
